We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+31.46%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$91.5M
AUM Growth
+$23.2M
Cap. Flow
+$1.78M
Cap. Flow %
1.95%
Top 10 Hldgs %
59.03%
Holding
57
New
10
Increased
4
Reduced
9
Closed
4

Top Buys

Rank Stock Value
1
STXS icon
Stereotaxis
STXS
+$4.59M
2
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.74M
3
PLX icon
Protalix BioTherapeutics
PLX
+$1.59M
4
HSTO
Histogen Inc. Common Stock
HSTO
+$1.07M
5
KBIO
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
+$969K

Top Sells

Rank Stock Value
1
NVDQ
Novadaq Technologies Inc.
NVDQ
+$2.52M
2
DYAX
DYAX CORPORATION
DYAX
+$2.28M
3
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$821K
4
BEAT
BioTelemetry, Inc.
BEAT
+$734K
5
INFU icon
InfuSystem Holdings
INFU
+$707K

Sector Composition

Rank Sector Weight
1 Healthcare 60.11%
2 Financials 1.25%
3 Communication Services 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STRR
51
DELISTED
Star Equity Holdings
STRR
– –
-733
Closed -$89K
VRTX icon
52
Vertex Pharmaceuticals
VRTX
$121B
– –
-8,600
Closed -$689K
ANAC
53
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
– –
-106,993
Closed -$598K
1 2
3

Similar funds

CDMG
Creek Drive Management Group San Francisco, California $439M AUM
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
WAS
Winch Advisory Services Appleton, Wisconsin $438M AUM 17.59% 1-Year Est. Return

DAFNA Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, DAFNA Capital Management held 57 positions worth $91.5M, up 34% from $68.3M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

DAFNA Capital Management's Q3 2013 filing shows 10 new, 4 increased, 9 reduced and 4 closed positions. Its largest new stake was Ampio Pharmaceuticals Inc.: 1,419 shares worth $3.19M. The largest sale was Novadaq Technologies Inc., an estimated $2.52M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 61% a quarter earlier, followed by Financials and Communication Services.

  • DAFNA Capital Management's largest Q3 2013 buy was Ampio Pharmaceuticals Inc.: 1,419 shares worth $3.19M.
  • DAFNA Capital Management added most to Stereotaxis in Q3 2013, an estimated $4.59M increase.
  • DAFNA Capital Management's biggest Q3 2013 reduction was Novadaq Technologies Inc., cutting an estimated $2.52M.
  • DAFNA Capital Management fully exited InfuSystem Holdings in Q3 2013, selling an estimated $707K.
  • DAFNA Capital Management's ten largest holdings make up 59% of its $91.5M portfolio in Q3 2013.
  • DAFNA Capital Management opened 10 new positions and closed 4 in Q3 2013.
  • DAFNA Capital Management's portfolio value rose 34% quarter-over-quarter to $91.5M.

Based on DAFNA Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.